revolade
novartis europharm limited - eltrombopag - purpura, trombocitopén, idiopátiás - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 és 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 és 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
gamma-venin p
aventis behring gmbh - immunoglobulins, normal human
adenosan por a.u.v.
medicus partner gyógyszer-, könyv- és muszerkereskedelmi kft. - cruciferaceae por, immunglobulinok - por belsoleges oldathoz - galamb (dísz galamb)
16% human gamma-globulin oldatos injekció
human bioplazma kft. - immunglobulin (humán) -
16% human gamma-globulin oldatos injekció, 5 ml
human bioplazma kft. - immunglobulin (humán) -
humaclot 500 ne por és oldószer oldatos injekcióhoz
human bioplazma kft. - humán viii-as véralvadási faktor -
humaclot 1000 ne por és oldószer oldatos injekcióhoz
human bioplazma kft. - humán viii-as véralvadási faktor -
humaglobin liquid 50 g/l oldatos infúzió
human bioplazma kft. - immunglobulin (humán) -
hizentra
csl behring gmbh - humán normál immunglobulin (scig) - immunológiai fogyatékossági szindrómák - immunrendszer sera, immunglobulinok, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.
humaglobin 0,5 g/10 ml por és oldószer oldatos infúzióhoz
human bioplazma kft. - immunglobulin (humán) -